Hillsdale Investment Management »

Anika Therapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $368k 25k 14.50
2014-06-30 $320k 6.9k 46.38
2012-03-31 $418k 33k 12.55

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Enerflex (EFXT)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Manulife Finl Corp (MFC)
Fortis (FTS)
Centerra Gold (CGAU)
Barrick Mining Corp (B)
Precision Drill (PDS)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Suncor Energy (SU)

View all positions for Hillsdale Investment Management

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Morgan Stanley
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Boothbay Fund Management
Renaissance Technologies
Dimensional Fund Advisors
Capital Management Corporation
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics